INTRODUCTION

OBSTRUCTIVE SLEEP APNEA (OSA) WITH DAYTIME HY-PERSOMNOLENCE IS PRESENT IN AT LEAST 12 MILLION ADULTS IN THE UNITED STATES.
1 TWO THIRDS of adults with OSA complain of significant sleepiness and/or fatigue at presentation. 2 Yet, therapies may not fully reverse hypersomnolence. [3] [4] [5] [6] Thus, residual sleepiness in adults treated for OSA is a significant health concern.
Adult male mice exposed to hypoxia/reoxygenation patterns similar to those present in patients with severe OSA develop lasting hypersomnolence and objective sleepiness. 7 These wake impairments are associated with oxidation and nitration in wakeactive regions. [7] [8] [9] Both the oxidative injury and wakefulness impairments are dependent upon nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity. 9 Thus, the long-term intermittent hypoxia (LTIH)-induced residual wake impairments are a consequence of NADPH oxidase-dependent oxidative injury in selective brain regions. Perinatal LTIH exposure in male and female rat pups results in wake impairments lasting at least 3 weeks, associated with alterations in dopaminergic signaling. 10, 11 Studies have shown sex differences in dopaminergic receptor and reuptake proteins, yet show no differences of posthypoxia sleepwake architecture. 10, 11 Whether there are sex differences in wakeimpairment effects of LTIH in young adults is not known.
Sex differences have been shown for oxidative brain injuries. In humans, female sex is associated with improved outcomes for both cerebrovascular insults and Parkinson disease. 12, 13 In experimentally induced oxidative brain injuries in mice, premenopausal females confer protection relative to age-matched males or ovarectomized age-matched females. 14 These findings suggest that endogenous estrogen plays an important role in mechanisms of protection from brain oxidative injuries (for review, see reference 15). We hypothesized that premenopausal female mice, relative to age-matched male mice, would show protection from LTIH oxidative injury and wake impairments.
The purpose of the studies presented here was to compare the effects of LTIH exposure in young adult male and female mice on wake impairments and oxidative injury to wake regions in the brain. We first determined whether hypoxia/reoxygenation events, modeling severe OSA hypoxia/reoxygenation, manifest as residual hypersomnolence and shortened sleep latencies in females, as we have found in males. In the present work, we have found that females appear to be resistant to LTIH wake impairments, both hypersomnolence and sleepiness. To gain further insight into potential mechanisms of sleepiness in women with OSA, we next measured sleep-latency responses in male and female mice exposed to short-term sleep loss. In contrast with the lack of LTIH effect on wake function in female mice, female mice showed greater sleepiness after short-term sleep loss and more robust slow-wave (delta) activity across recovery. We then determined whether LTIH induces NADPH oxidase activation and oxidative injury in select wake-active brain regions in female mice, as has been shown in male mice. We have found less baseline oxidative injury in female mice, such that, despite LTIH increases in carbonylation in this sex, levels remained lower than those of male mice under sham-LTIH conditions. This work suggests that females are susceptible to the physiologic perturbances of OSA, but, because of a lower oxidative injury at baseline, are protected, at least temporarily, from the intermittent-hypoxemia effects. At the same time, female mice experience greater objective sleepiness in response to sleep disruption, as compared with age-matched male mice. Elucidation of sex differences in OSA wake impairments will advance our understanding of clinically significant polysomnographic indexes for each of the 2 sexes.
METHODS
Animals
Eight-to 10-week-old male and female littermate C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were studied. Methods and study protocols were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. Protocols conformed to the revised National Institutes of Health Office of Laboratory Animal Welfare Policy. Food and water were provided ad libitum. Mice were confirmed pathogen free at the time of behavioral studies.
LTIH Protocol
Detailed descriptions of the LTIH protocol were recently published. 9, 16 An automated nitrogen/oxygen delivery profile system (Oxycycler model A84XOV; Biospherix, Redfield, NY) delivered 100% nitrogen to the chambers to produce rapid brief reductions in the fraction of inspired oxygen (FiO 2 ) within the chamber from 21% to 10% for 5 seconds every 90 seconds. Arterial oxyhemoglobin saturation in males and females at a constant FiO 2 of 21% was 95% to 98% and at an FiO 2 of 10% was 83% to 86%. There were no sex differences in oxyhemoglobin saturation. Sham LTIH, with ambient FiO 2 fluctuations from 21% to 19% every 90 seconds, held arterial oxyhemoglobin values constant between 96% and 98%. Both conditions were produced for 10 hours of the lights-on period for a total of 8 weeks. Prior to exposures, during exposures, and across recovery and sleep studies, lights were turned on at 7:00 AM and turned off at 7:00 PM Humidity, ambient CO 2 , and environmental temperature were held constant.
Sleep-Wake, Multiple Sleep Latency, and Enforced-Wakefulness Protocols
Following 8 weeks of LTIH or sham LTIH exposures, mice were returned to normoxic conditions and randomly assigned to sleep or biochemical assays. Mice randomly assigned to sleep studies underwent surgical implantation of electroencephalographic and electromyographic electrodes after 1 week in normoxia using previously described methods. 17 Mice were connected to recording cables in individual cages, and sleep recordings were begun 7 days postoperatively. Baseline sleep was recorded for 6 days. On baseline recording day 6, a murine Multiple Sleep Latency Test 18 was performed across 4 nap opportunities between 2:00 PM and 4:00 PM to measure baseline sleep propensity. On recording day 7, enforced wakefulness was performed (using gentle air puffs and placement of cotton for nest building) with verification of electroencephalogram tracings for 6 hours of the light period (8:00 AM to 2:00 PM), followed by a second sleep-latency test and then recovery sleep was recorded for 12 hours. The behavioralstate acquisition and analysis program used for these studies was previously described, 19 with modifications and behavioral-state parameters. 17, 18 Primary variables were total wake time per 24 hours, total non-rapid eye movement (NREM) sleep time per 24 hours, rapid eye movement (REM) sleep time per 24 hours, length of average wake bout, and average sleep latency before and after short-term sleep loss.
NADPH Oxidase Subunits Rac 1 and p67 phox
Translocation of NADPH oxidase cytosolic subunits to the membrane indicates NADPH oxidase activation, as measured by Western. 20 Cytosolic and membrane/organelle fractions in WT mice exposed to LTIH or sham LTIH (n=5 per condition) were separated using 100,000 G × 60 minutes. 20 Polyclonal rabbit antimouse rac 1 and p67 phox (1:500, Upstate, Lake Placid, NY) were added to homogenates and bound by a horseradish peroxidase conjugated secondary anti-IgG (1:15,000, 12-349, Upstate) for detection with chemiluminescence (SuperSignal Ultra, Pierce, Rockford, IL). Images were analyzed with National Institutes of Health Image Analysis, using band densities for statistical comparisons (rac: membrane fraction:cytosolic/organelle fraction) and p67 phox : membrane density, as the cytosolic/organelle fraction density was too weak to measure). Preliminary trials showed weaker immunoreactivity 2 weeks into recovery. Thus, these measures were made on the last day of LTIH or sham LTIH.
Measurement of Carbonyl Proteins and F 2 Isoprostanes
For measurement of protein carbonylation, macrodissections of the locus coeruleus in the dorsal pons were procured for protein purification. Purified protein (20 µg) was run on enzyme-linked immunosorbent assay (ELISA) using a commercially available ELISA kit (Zentec PC Test, Zenith Technology, Dunedin, New Zealand) as recently described. 8, 9 Measurement of isoprostane, d 4 -8,12-iso-iPF 2α -VI, (iPF 2α -VI) was performed 2 weeks into recovery, as previously described, 21, 22 using whole forebrains in mice following conditions of LTIH and sham intermittent in male and female mice (n = 5/group). Total lipid was extracted with ice-cold Folch solution. 21 Lipids were then subjected to base hydrolysis with aqueous 15% KOH and were then incubated at 45°C for 1 hour for measurement of total iPF 2α -VI using ion chemical ionization gas chromatography-mass spectrometry assay, as previously described.
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Statistical Analysis
Values reported represent mean ± SEM. To assess LTIH and sex differences in sleep-wake parameters, 2-way analysis of variance (ANOVA) was used with the dependent variables total wake time and wake bout length (Bonferroni corrected for the three variables) and the independent variables intermittenthypoxia condition and sex. To assess sleep loss and intermittenthypoxia effects on sleep latencies in female mice, 2-way ANOVA was used with sleep latency as the dependent variable and sleep loss or rested conditions and LTIH or sham LTIH conditions as the 2 independent variables. To determine whether female mice developed increased isoprostanes with LTIH exposure, 1-way ANOVA comparing LTIH and sham LTIH was performed. Similarly, to determine whether LTIH activated NADPH oxidase, 1-way ANOVA was used comparing LTIH and sham LTIH membrane-band densities. The latter was done independently for the 2 wake sites (basal forebrain and locus coeruleus) in females. To ascertain sex-specific gene-response differences, 2-way ANOVA was used with copy number for each of the 4 genes as a primary variable (Bonferroni corrected), using independent variables of sex and LTIH condition. The null hypothesis was rejected for probabilities < .05.
RESULTS
Female Mice Confer Resistance to LTIH Reduced Wake Times
Wake, NREM sleep, and REM sleep times per 24 hours were measured in female mice following conditions of sham LTIH (n = 13) and LTIH (n = 14) and compared with values obtained in male mice following conditions of sham LTIH (n = 15) and LTIH (n = 15). Results are summarized in Figure 1 . Across conditions of sham LTIH, there were no sex differences in wake time (females wake time= 795 ± 26 minutes and males= 770 ± 25 minutes, t = 0.8, NS). Comparing sham LTIH to LTIH, male mice showed a large reduction in wake time (173 minutes less wake, t = 5.9, p < .001). In contrast, female mice showed no effect of LTIH on total wake time (wake time: sham LTIH 795 ± 26 minutes vs LTIH 767 ± 33 minutes, t = 0.9, NS). Thus, wake time in males following LTIH exposure was significantly less than wake time in females after LTIH exposure (difference, 170 minutes more wake time in females after LTIH, t = 6.1, p < .001.
LTIH effects on NREM sleep directly opposed the LTIH effects on wakefulness. In males, LTIH increased NREM sleep time by 130 minutes, compared with sham LTIH, (t = 4.4, p < .001). In females, LTIH had no effect on NREM sleep time. The difference of 37 more minutes after LTIH was not significant, (t = 1.3. There was a large increase in REM sleep after LTIH in males (42 minutes, t = 2.8, p < .05) but no change in REM sleep time in females across LTIH conditions (mean difference 10 minutes, t = 0.3, NS).
There were also sex effects on sleep architecture for the light and dark periods of the 24-hour cycle, as summarized in Figure  1B . Male mice showed a larger diurnal variation for sleep in the lights on period (200 minutes more sleep in lights on, (t = 7.46, p < .001). In contrast, females had less light-to-dark difference (100 minutes more sleep in lights on, t = 3.7, p < .01). Consistent with previous findings, males showed remarkably parallel increases across the entire 24-hour period. 7 There was a 77-minute increase in LTIH-exposed mice, relative to sham-LTIH mice (t = 2.9, p < .05) in the lights-on period and a 77-minute increase in the dark period in LTIH mice relative to sham LTIH mice (t = 2.9, p < .05). In contrast, females showed no difference in either the light (difference, 44-minute increase, t = 1.6, NS) or the dark period (28-minute decrease, t = 1.0, NS).
Sleep-Latency Responses to LTIH and Sleep Loss are Sex Specific
Murine multiple sleep latency testing was performed on males and females following conditions of sham LTIH and LTIH, and comparisons were drawn between males and females across the 2 LTIH conditions.
Baseline Sleep Latencies for Sham LTIH
A summary of results is depicted in Figure 2 . The baseline (rested) mean sleep latency for male and female mice following sham-LTIH conditions did not differ. The mean latency for males was 13.6 ± 0.7 minutes (n = 11), and, for females, the latency was 12.9 ± 1.0 minutes (n = 12, t = 0.5, NS).
Baseline Sleep Latencies for LTIH Across Sexes
Male mice exposed to LTIH had an average latency of 9.6 ± 1.1 minutes (n = 12), and female mice following LTIH had a latency of 13.1 ± 1.2 minutes, for a difference of -3.5 minutes (t = 2.7, p < .05).
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Effects of LTIH on Baseline Latency for Each Sex
There was an effect of intermittent-hypoxemia condition on sleep latency in male mice (LTIH vs sham LTIH difference was -4.0 minutes, t = 3.1, p < .05). In contrast, there was no intermittent-hypoxemia effect on sleep latencies in female mice (difference +0.2 minutes, t = 0.3, NS). In summary, there were no sex differences in baseline sleep latencies for sham LTIH, and LTIH did not affect the sleep latency in female mice, as it did affect sleep latency in male mice.
Both males and females had significant effects of enforced sleep loss on sleep latencies for conditions of sham LTIH and LTIH.
Effects of Sleep Deprivation on Sham LTIH Sleep Latency for Each Sex
Short-term sleep loss in males exposed to sham LTIH shortened the sleep latency by 4.7 minutes (t = 3.5, p < .01). In contrast, short-term sleep loss in females exposed to sham LTIH shortened the sleep latency by 8 minutes (t = 6.6, p < .001).
Effects of Sleep Deprivation on LTIH Sleep Latency for Each Sex
Short-term sleep loss in male mice exposed to LTIH shortened the sleep latency by 7 minutes (t = 5.4, p < .001). A similar effect of sleep deprivation was seen in females exposed to LTIH, with the sleep latency shortened by 7 minutes, (t = 5.8, p < .001).
Effects of Sleep Deprivation on Sham-LTIH Sleep Latency Across Sexes
Following short-term sleep deprivation, the sham LTIH-exposed male mice had an average sleep latency of 8.9 ± 1.1 minutes (n = 11), whereas, after short-term sleep deprivation, sham LTIHexposed female mice had an average sleep latency of 4.8 ± 0.5 minutes (difference +4.1 minutes, t = 3.2, p < .05).
Effects of Sleep Deprivation on LTIH Sleep Latency Across Sexes
Following LTIH and short-term sleep deprivation, sleep latencies were shorter in males than females. After short-term sleep loss, LTIH males had an average sleep latency of 2.6 ± 0.4 minutes (n = 12). In contrast, LTIH females after short-term sleep loss had an average sleep latency of 5.9 ± 0.7 minutes, for a difference of +3.2 minutes (t = 2.7, p < .05), unchanged from the sham-LTIH sleep-deprivation baseline. In summary, in contrast with the LTIH effects that were more pronounced in males, the sleep-loss effects on sleep latency were greater in female mice for sham-LTIH conditions. However the combination of sleep loss and LTIH resulted in a shorter sleep latency in males.
Female Mice Confer Resistance to LTIH-Induced Disruption in SlowWave Activity
Delta decline across the lights-on period was determined for 9 female mice exposed to LTIH and 9 female mice exposed to sham LTIH, and data are presented in Figure 3 . There were no sex differences in delta decline for sham-LTIH conditions across the lights-on period in rested mice. In contrast with LTIH effects reported in male mice, 7, 8 female mice showed no difference in maximal delta power percentage at the onset of the lights-on period (sham LTIH: 171% ± 7% and LTIH; 179% ± 15%, t = 0.47, NS). Similarly, in female mice, the slope of delta decline did not differ across LTIH conditions (sham LTIH: -4.4 ± 0.4 and LTIH: -5.1 ± 0.9, t = 0.74, NS).
Delta activity in response to 6 hours of enforced wakefulness was observed in 9 female and 9 male mice exposed to sham LTIH and 9 female and 9 male mice exposed to LTIH. Data are not shown but are presented below. A large increase in delta activity
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Female Intermittent Hypoxia Resistance-Sanfilippo-Cohn et al was observed in female mice for the first hour of recovery sleep for both groups of female mice (sham LTIH mice: 265% ± 23% and LTIH mice: 285% ± 34%, t = 0.83, NS). In contrast, male mice exposed to sham LTIH had a smaller increase after 6 hours of enforced wakefulness, relative to female mice exposed to sham LTIH (169% ± 32%, t = 4.3, p < .01). Differences in delta decline were even larger across sexes for mice exposed to LTIH. Males exposed to LTIH showed a minimal increase in delta activity for the first hour of recovery sleep (138% ± 28%, t = 6.5, p < .001). In summary, female mice showed larger increases in relative delta power after short-term sleep loss, and this increased delta response in females was not affected by LTIH, as it was in males.
No Sex Differences in NADPH Oxidase Activation in Response to LTIH
Densities of membrane-bound p67 and rac 1 subunits were used as an index measure of NADPH oxidase activation. 20 For NADPH oxidase subunit rac 1, there was no sex effect in sham-LTIH mice ( Figure 4A ) (Bonferroni multiple comparison t = 1.7, NS). Both sexes showed increased rac 1 translocation to the membrane in response to LTIH (females t = 3.3, p < .01; males t = 2.8, p < .05). There was no difference between LTIH male or female rac 1 densities (t = 2.2, NS). Similar findings were observed with NADPH oxidase subunit p67 ( Figure 4B ), although the magnitude of LTIH response for each sex was greater. There were no differences in baseline p67 membrane densities (t = 0.02, NS). Females and males each showed robust translocation in response to LTIH (t = 7.5, p < .001 and t = 6.0, p < .01, respectively). There were no sex differences in LTIH membrane densities (t = 1.5, p < .05).
Sex-Specific Differences in Baseline Carbonylated Proteins in Wake-Active Brain Regions and Reduced Carbonylation in LTIH Females
There were large sex and LTIH effects on the concentration of carbonyl protein in the locus coeruleus (F = 18, p < .0001) ( Figure 5A ). Carbonyl content in female sham-LTIH mice was lower than in males (t = 4.6, p < .001). LTIH increased carbonyl content in females (t = 4.8, p < .001) and also in males (t = 2.7, p < .05). However, carbonyl content was significantly lower in female mice exposed to LTIH than in males under the same exposure (t = 3.3, p < .01) and, in fact, was close to the level of carbonylation in males under sham conditions (t = 0.7, NS).
Females Show Greater Lipid Peroxidation in Response to LTIH
Both males and females showed LTIH increases in isoprostane d 4 -8,12-iso-iPF 2α -VI (iPF 2α -VI) levels ( Figure 5B ). There was no sex effect on sham LTIH iPF 2α -VI, (t = 1.6, NS). Females and males showed increases in iPF 2α -VI in response to LTIH (females: t = 4.2, p < .001 and males: t = 2.6, p < .05). However, the increase in females was larger, such that the iPF 2α -VI levels in LTIH females were significantly higher than the levels in LTIH-exposed males, (t = 3.2, p < .01.
DISCUSSION
We have obtained direct evidence for important sex differences in neurobehavioral and neurochemical responses to LTIH, modeling the hypoxia/reoxygenation events in OSA, and we have also observed significant sex differences in the response to short-term sleep deprivation. In contrast with the robust wake impairments observed in young adult male mice following LTIH, age-matched female mice confer resistance to LTIH-induced shortened total wakefulness time across a 24-hour period and increased objective sleepiness, as measured by the murine multiple sleep latency test. Previously, we have shown that oxidative injury contributes substantially to the LTIH-induced wake impairments in male mice. 10, 11 In the present work, we have obtained evidence that female mice are susceptible to LTIH-induced NADPH oxidase activation and both lipid peroxidation and carbonylation injuries. In light of the strong proinflammatory response in female mice, we suspect that the resistance to neurobehavioral sequelae is short lived. The proinflammatory response is likely to increase oxidative neural injury so that, ultimately, the female mice are expected to have sufficient carbonylation injury. 20 A unique advantage observed in the females was lower baseline carbonylation. Thus, whether the females have a more robust antioxidant capacity at baseline and throughout LTIH should next be determined.
The LTIH Model of Hypoxia/Reoxygenation Events of Sleep Apnea
LTIH was achieved by way of fluctuating the levels of nitrogen and oxygen in the chambers in which mice resided. This model provides the capability to explore long-term effects of hypoxia/reoxygenation events in an intact in vivo preparation. A very similar protocol has been implemented in young rats and mice to show LTIH-induced cognitive dysfunction and oxidative injury in the cortex, hippocampus, and wake-active brain regions. [9] [10] [11] [23] [24] [25] Findings with this model are consistent with brain injury identified in persons with OSA. 26, 27 By design, the LTIH model excludes hypercapnic, arousal, and upper-airway perturbances. Further studies are needed to determine if less-severe LTIH can induce these injuries and if hypercapnia, upper-airway responses, and arousals result in either additive or synergistic injuries.
Sex Differences in Wake Function Following LTIH
Several lines of evidence support the concept that young adult female mice are less susceptible to wake impairments induced by LTIH, as in our protocol. First, the study was adequately powered to detect 10% or greater changes for both wake time and sleep latency in females, based on sham-LTIH sleep-latency group average and variability. Indeed, we were able to show in this study with the same mice that female mice are more susceptible to sleepiness following 6 hours of enforced wakefulness in the lightson period at the same circadian time point when LTIH effects were measured. Moreover, female mice showed more pronounced slow-wave activity responses than male mice in recovery sleep following short-term sleep loss, and this response is not disturbed by LTIH in the females, as it is in males. Collectively, the present A. Following LTIH, carbonyl is increased in both sexes but is far higher in males. *p < .05; **p < .01 and ***p < .001. B. Homogenized tissue samples were collected for measurement of isoprostane, 8,12-iso-iPF2-VI, from the cortex in female and male mice following 8 weeks of exposure to either LTIH or sham LTIH. Using an internal standard, levels were assayed by negative-ion chemical ionization gas chromatography and mass spectrometry. *p < .05; **p < .01; ***p < .001.
work identifies significant sex differences in young adult mice in responses to both LTIH and sleep loss. Sex differences in susceptibility to sleep loss and intermittent hypoxia raise the possibility that neurobehavioral consequences of OSA in humans may vary with sex. Future studies should examine whether the sex changes are related to menopause.
Previously, we showed that LTIH-induced wake impairments in male mice are a consequence of NADPH oxidase-dependent oxidative injury to wake-active regions. [9] [10] [11] We were surprised to see comparable NADPH oxidase activation in females. Westerns presently require macropunches of tissue; thus, the samples used in our assays include both glia and neurons. We have shown NADPH oxidase in wake-active neurons in the locus coeruleus and lateral basal forebrain. It is possible that females show a robust glial NADPH oxidase response to LTIH but less NADPH oxidase activation and injury in wake-active neurons. Immunohistochemistry and in situ hybridization studies may help determine whether the NADPH oxidase response in the 2 sexes occurs primarily in neurons or microglia. In light of the lower carbonylation in females at baseline and in response to LTIH, we suspect that young adult females are somehow protected from basal carbonylation, so that by the time the female mice completed 8 weeks of LTIH, they had not yet attained a critical level of oxidative damage to wake-active neurons to render them dysfunctional. We would predict then that longer exposures or more severe exposures are required for LTIH to result in residual hypersomnolence in young adult females.
The sex-dependent effects on baseline oxidation in wake-active regions may be related to antioxidant effects of estrogen. Estrogen has been shown to have multiple beneficial effects on redox status, including enhancing superoxide dismutase activity [28] [29] [30] and attenuating TNF-α and NFκβ responses in the brain. 31, 32 Carbonylation, rather than lipid peroxidation, predicts susceptibility to LTIH-induced wake impairments.
Many oxidative changes occur in the brain in response to LTIH, including nitration, lipid peroxidation, and oxidation. [7] [8] [9] 16, [23] [24] [25] What remains unclear is which of these redox responses contributes to the behavioral impairments observed with LTIH. Lipid peroxidation and carbonylation are believed to result in irreversible changes. 33 Consistent with previous studies, males and females showed LTIH increases in both lipid peroxidation and carbonylation. Females showed larger increases in isoprostane levels than males in response to LTIH and had higher absolute levels than males exposed to LTIH. In contrast, females had lower absolute carbonylation levels than males for both baseline and LTIH conditions. Carbonylation is a marker of cumulative oxidative injury. 33 Thus, females, at least in wake-active regions, show less baseline oxidative injury. Lower carbonylation in females at baseline might be attributed to activation of estrogen receptors, known to increase transcription of both glutathione peroxidase and superoxide dismutase. 28, 29 Future studies should examine baseline antioxidant activity in wake-active regions of male and female mice at baseline and the protective roles both estrogen and progesterone play in responses to LTIH.
Sex Differences in the Homeostatic Response to Short-Term Sleep Loss
In the present study, we found direct complimentary evidence for sex differences in sleep homeostasis. In healthy young individuals, homeostasis is best characterized by relative change in delta activity in NREM sleep. [34] [35] [36] Female mice showed larger increases in delta activity during recovery NREM sleep. Similar sex differences in sleep-loss responses have been shown for young adult humans. 37 Females show higher delta response to sleep loss in humans. 37 The second finding in the present study supporting increased homeostatic response to sleep loss in females is that the female mice showed larger reductions in mean sleep latency (objective sleepiness) after 6 hours of enforced wakefulness, confirmed polysomnographically. Thus, we have established sex differences in young adult mice in the homeostatic responses to sleep disruption, with differences in both delta response and sleep-latency response. In addition, we extend these findings to show that females show greater resistance to LTIH injury to the homeostatic mechanisms. We believe these sex differences will provide a valuable tool with which to delineate mechanisms of impaired homeostasis from hypoxia/reoxygenation events of sleep apnea.
Implications for Humans with OSA
Female mice showed greater sleepiness and a more robust homeostatic response to short-term sleep loss than age-matched male mice, while demonstrating resistance to wake impairments following hypoxia/reoxygenation events, modeling severe OSA. In light of these findings, we hypothesize that the polysomnographic findings more predictive of daytime wake impairments in young adult women would be sleep fragmentation and sleep disruption. Thus, upper airways resistance syndrome through sleep fragmentation may have profound effects on wake function in young adult women. While severe OSA is rare in premenopausal women, more women present to the sleep clinics with snoring, sleepiness, and fatigue who have high arousal indexes, without significant apneahypopnea events. These individuals respond symptomatically to continuous positive airway pressure (CPAP), but, because of the low apnea-hypopnea index (requiring 4% desaturations), these individuals do not qualify for CPAP reimbursement. It is hoped that the above-described animal studies will help justify clinical studies in young adult women looking at objective sleepiness and quality-of-life responses to CPAP for treatment of respiratory-related sleep fragmentation. Ideally, the polysomnographic indexes to define clinically significant OSA should be designed for each sex.
In contrast with the importance of sleep fragmentation in women, parameters characterizing hypoxia/reoxygenation events may provide greater predictive value in men. We suspect that this sex effect depends upon estrogen bioavailability, and studies are planned to determine the relative roles of estrogen and progesterone in this sex difference and if the sex effect is lost in women following menopause. It is hoped that this work in animal models begins a dialog to assess the clinical significance of sleep and oxygenation polysomnographic parameters, relative to age and sex.
